echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Another batch of strap purchases began: shattan, omeprazole, amoxicillin...

    Another batch of strap purchases began: shattan, omeprazole, amoxicillin...

    • Last Update: 2020-06-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Recently, Zhejiang University Jinhua Hospital official website hangs out Jinhua City Drug Mining Office issued "Jinhua City's first batch of drug belt procurement products to be shortlisted enterprise publicity", 22 drugs to carry out with volume procurement (the catalog details at the end of the article)According to the previous "Jinhua City Drug Supplies Band Collection Alliance Committee Drug Band Purchase Implementation Rules (First Batch)", pharmaceutical companies quoted according to the current Zhejiang Province medical insurance payment standards, the decline of drugs must not be less than 10%echoed the "Notice on a number of policy measures to further deepen the reform of the medical and health system through the centralized procurement and use of drugs as a breakthrough" issued a day ago (29th) by the Leading Group of the State Council on the centralized procurement and use of medicines- - to this end, the amount of water and silver procurement, the state and the local drip water does not leak, as previously predicted, the state and the local at the same time, firepowertime has comethe logic of the price reduction of pharmaceutical companies, the power of the hospital to let go
    however, with volume procurement of the core volume price linked, in many industries, including the same pharmaceutical field OTC procurement is common sense consensus - buy more, can be cheaper? How much, the larger the price, the better to talk aboutCan be in the public hospital drug procurement, the amount of procurement is now really on the ground implementation, and has become an industry eventan industry expert who did not want to be named, told the author that this may be from even after the zero-plus, why the hospital still hold the drug do not put on the reasonHuang Yong, marketing director of's Weijiang Pharmaceutical industry, told Saibai Blue that the previous volume of public hospitals hung up the net, because of various reasons, the procurement department did not promise or promise to be able to cash in the amount, resulting in a lot of illsNow the national band procurement implementation is very successful core, is the health insurance supervisor of medical insurance payment and bidding, urge the hospital to report and step by step to implement the indicators, provincial hospitals, department doctors, we all have indicatorshave indicatorsmanufacturers have indicators to land, of course, is willing to drop in the end, take the initiative to cancel the intermediate linkIn fact, although the purchase price of the volume plummeted, as long as the manufacturer confirmed the price, there is still room for profit, but agents or self-employed team does not need, clinical customer maintenance is basically nohospitals are the same, medical insurance payment balance, adjust the price of medical services and other increasein hospital disposable income, promote pay reform, mobilize the enthusiasm of medical personnel, in the new procurement model is not "lost"after the volume of procurement ecology, increased concentration, professionalizationChina bid network director Li Zhixuan analysis, the current national mining project pilot band volume pressure price strength, the full implementation of the volume procurement, medical insurance products should be fully expanded face collection, and a comprehensive price reduction, even if the process will have individual manufacturers to avoid the catalog of luck, but ultimately can not escape, innovative drugs in the domestic road is still long, pharmaceutical companies can now improve the overall professional level in the post-band procurement era, the industry concentration will be greatly increased, a pharmaceutical policy research institute experts told Cypress Blue, now the industry is over-dispersed, the concentration of increased cost reduction, efficiency, which is a good thing for the industry specifically, Huang Yong believes that the state through the volume of procurement significantly lower drug prices, reduce health care expenditure, to ensure that health insurance funds do not wear the bottom Speed up consistency evaluation, reduce drug prices to promote low-capacity enterprises out, through supply-side reform, optimize the industrial environment in the hospital port, strengthen the fight against pharmaceutical commercial bribery, strengthen medical integrity, make reasonable clinical use of drugs, reduce or eliminate the impact of customer maintenance, thereby reducing the impact of practitioners, improve the quality of the stock of personnel, directly improve the level of business future, production capacity-oriented enterprises, the future by the production capacity advantage to survive, such as Huahai; price linkage can be suspended
    however, there is also an analysis that the positive significance of the volume procurement is obvious to all, but to observe the relevant pharmaceutical companies share prices ups and downs, investors may need time to understand this policy, in the short term may affect enthusiasm, the other three selected procurement rules, there may also be other pharmaceutical companies on the consistent evaluation of the input in fact, the biggest conflict with band procurement is the national price linkage At present, most of the country's provinces, most of the enterprises are required to declare the price of other provinces, from which to choose a price as their own hanging net price, some provinces require the lowest price in the country, the lowest price in ten provinces but in the procurement mode of quantity procurement, volume price-linked, each province, procurement alliance through negotiations to get the price is likely to be different, so that the re-price linkage has no meaning, can be used as a reference for negotiations, but specific also according to the use of talk, otherwise it will affect the confidence of pharmaceutical companies to reduce prices have a volume price linked, the price linkage may not be necessary in addition, with the in-depth development of the volume procurement, drug research and development, hospital promotion, pharmaceutical enterprise compliance, commercial circulation reshuffle intensified, the acceleration of industry mergers and acquisitions will have a clear impact As for whether it's a gradual process or an immediate effect, there may be an answer soon attached:
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.